BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 6455958)

  • 1. Small synthetic peptides with affinity for proteases in coagulation and fibrinolysis: an overview.
    Claeson G; Aurell L
    Ann N Y Acad Sci; 1981; 370():798-811. PubMed ID: 6455958
    [No Abstract]   [Full Text] [Related]  

  • 2. Mapping the active sites of bovine thrombin, factor IXa, factor Xa, factor XIa, factor XIIa, plasma kallikrein, and trypsin with amino acid and peptide thioesters: development of new sensitive substrates.
    McRae BJ; Kurachi K; Heimark RL; Fujikawa K; Davie EW; Powers JC
    Biochemistry; 1981 Dec; 20(25):7196-206. PubMed ID: 6976185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactivity of bovine blood coagulation factor IXa beta, factor Xa beta, and factor XIa toward fluorogenic peptides containing the activation site sequences of bovine factor IX and factor X.
    Castillo MJ; Kurachi K; Nishino N; Ohkubo I; Powers JC
    Biochemistry; 1983 Mar; 22(5):1021-9. PubMed ID: 6601494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active-site mapping of bovine and human blood coagulation serine proteases using synthetic peptide 4-nitroanilide and thio ester substrates.
    Cho K; Tanaka T; Cook RR; Kisiel W; Fujikawa K; Kurachi K; Powers JC
    Biochemistry; 1984 Feb; 23(4):644-50. PubMed ID: 6370301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New chromogenic substrates for thrombin with increased specificity.
    Kolde HJ; Eberle R; Heber H; Heimburger N
    Thromb Haemost; 1986 Oct; 56(2):155-9. PubMed ID: 2949389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coagulation factor IX residues G4-Q11 mediate its interaction with a shared factor IX/IXa binding site on activated platelets but not the assembly of the functional factor X activating complex.
    Ahmad SS; Wong MY; Rawala R; Jameson BA; Walsh PN
    Biochemistry; 1998 Feb; 37(6):1671-9. PubMed ID: 9484238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The kinin system: its relation to blood coagulation, fibrinolysis and the formed elements of the blood.
    Movat HZ
    Rev Physiol Biochem Pharmacol; 1978; 84():143-202. PubMed ID: 152965
    [No Abstract]   [Full Text] [Related]  

  • 8. Chromogenic peptide substrates. Their use for the assay of factors in the fibrinolytic and the plasma kallikrein-kinin systems.
    Friberger P
    Scand J Clin Lab Invest Suppl; 1982; 162():1-298. PubMed ID: 6221396
    [No Abstract]   [Full Text] [Related]  

  • 9. Theory of blood coagulation in disseminated intravascular coagulation (D. I. C.).
    Murano G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1972; 97(1):5-19. PubMed ID: 4114585
    [No Abstract]   [Full Text] [Related]  

  • 10. The Hageman factor dependent pathways of coagulation, fibrinolysis, and kinin-generation.
    Kaplan AP; Meier HL; Mandle R
    Semin Thromb Hemost; 1976 Jul; 3(1):1-26. PubMed ID: 139682
    [No Abstract]   [Full Text] [Related]  

  • 11. Proteolytic activation of tissue plasminogen activator by plasma and tissue enzymes.
    Ichinose A; Kisiel W; Fujikawa K
    FEBS Lett; 1984 Oct; 175(2):412-8. PubMed ID: 6566616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A coagulation pathway on bovine aortic segments leading to generation of Factor Xa and thrombin.
    Stern DM; Nawroth PP; Kisiel W; Handley D; Drillings M; Bartos J
    J Clin Invest; 1984 Dec; 74(6):1910-21. PubMed ID: 6439737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assay of coagulation proteases using peptide chromogenic and fluorogenic substrates.
    Lottenberg R; Christensen U; Jackson CM; Coleman PL
    Methods Enzymol; 1981; 80 Pt C():341-61. PubMed ID: 6210826
    [No Abstract]   [Full Text] [Related]  

  • 14. Intrinsic versus extrinsic coagulation. Kinetic considerations.
    Warn-Cramer BJ; Bajaj SP
    Biochem J; 1986 Nov; 239(3):757-62. PubMed ID: 3493767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High molecular weight kininogen protects human plasma kallikrein and factor XIa against inactivation by plasma protease inhibitors.
    Schapira M; Scott CF; Colman RW
    Trans Assoc Am Physicians; 1981; 94():190-7. PubMed ID: 6979819
    [No Abstract]   [Full Text] [Related]  

  • 16. Experience with chromogenic substrates in studies of clotting and fibrinolytic systems.
    Chmielewska J; Latallo ZS
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):111-4. PubMed ID: 6177591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coagulation-fibrinolytic mechanism and the action of heparin.
    Rosenberg RD
    Adv Exp Med Biol; 1975; 52():217-37. PubMed ID: 235831
    [No Abstract]   [Full Text] [Related]  

  • 18. Assay with chromogenic substrates of in vivo activated proteases.
    Fässler H; Duckert F; Marbet GA
    Haemostasis; 1978; 7(2-3):158-63. PubMed ID: 149048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The binding of low molecular weight heparin to hemostatic enzymes.
    Jordan RE; Oosta GM; Gardner WT; Rosenberg RD
    J Biol Chem; 1980 Nov; 255(21):10073-80. PubMed ID: 6448845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorogenic peptide substrates for proteases in blood coagulation, kallikrein-kinin and fibrinolysis systems.
    Iwanaga S; Morita T; Kato H; Harada T; Adachi N; Sugo T; Maruyama I; Takada K; Kimura T; Sakakibara S
    Adv Exp Med Biol; 1979; 120A():147-63. PubMed ID: 158955
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.